Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹62,015.45Qualified Make: NOVO NORDISK
Model: NOVO NORDISK 250IU
Title: INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII - 250IU C 13 1 BASEMENT 2ND FLOOR 3RD FLOOR BLOCK C WAZIRPUR WAZIRPUR INDUSTRIAL AREA NORTH WEST DELHI DELHI 110052 | NORTH DELHI | DELHI | 110052 | Make: NOVO NORDISK
Model: NOVO NORDISK 250IU
Title: INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII - 250IU | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
12 Dec 2023, 1:00 pmClosed
INJECTION RECOMBINANT HUMAN COAGULATION FACTOR
5669032
GEM/2023/B/4275016
Two Packet Bid
INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII 250IU
GeM Contract
15 days
Delhi; West Delhi
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to A. C. SURGIPHARMA PRIVATE LIMITED
₹62,015.45
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII -250IU | NOVO NORDISK / NOVO NORDISK 250IU | HSN not specified by seller | 35 vials | 1,771.87 | 62,015.45 |
7 documents required · 7 mandatory
2 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| INJECTION RECOMBINANT HUMAN COAGULATION FACTOR | Vivek Kumar 110015,ESIC MODELHOSPITAL BASAIDARAPUR NEW DELHI | 35 | 15 days |
Exempted
16 Dec 2023
2 Dec 2023
12 Dec 2023
contract_GEMC-511687788049470.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5669032.pdf
GEM_BID
250iu_2023-12-01-12-57-51_17d7cd56ea9dc9e08c01c9e25af101ec.pdf
SPECIFICATION
1701417961.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .